Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anna J. M. van de Sande"'
Autor:
Natasja Hendriks, Sjoerd H van der Burg, Ziena Abdulrahman, Noel F C C de Miranda, Edith M G van Esch, Peggy J de Vos van Steenwijk, Antonios Somarakis, Arnold J Kruse, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Loes F S Kooreman, Brigitte F M Slangen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background The complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Externí odkaz:
https://doaj.org/article/ae2985823b1043c281f9a4695715eadb
Autor:
Anna J. M. van de Sande, Coen M. Schreuder, Romy van Baars, Margot M. Koeneman, Cornelis G. Gerestein, Arnold-Jan Kruse, Folkert J. van Kemenade, Sten P. Willemsen, Heleen J. van Beekhuizen
Publikováno v:
Obstetrics and Gynecology, 139(3), 417-422. Lippincott Williams & Wilkins
Obstetrics and Gynecology, 139(3), 417-422. LIPPINCOTT WILLIAMS & WILKINS
Obstetrics and Gynecology, 139(3), 417-422. LIPPINCOTT WILLIAMS & WILKINS
OBJECTIVE: To evaluate the efficacy and long-term outcome of repeat large loop excision of the transformation zone in women with residual or recurrent cervical intraepithelial neoplasia.METHODS: PALGA (the Dutch Pathology Registry), a database of dei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c16913a041ca4d17f3f5395601f1c2
https://doi.org/10.1097/aog.0000000000004663
https://doi.org/10.1097/aog.0000000000004663
Autor:
Ziena Abdulrahman, Natasja Hendriks, Arnold J Kruse, Antonios Somarakis, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Noel F C C de Miranda, Loes F S Kooreman, Brigitte F M Slangen, Sjoerd H van der Burg, Peggy J de Vos van Steenwijk, Edith M G van Esch
Publikováno v:
Journal for ImmunoTherapy of Cancer, 10(11). BMJ PUBLISHING GROUP
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd
Journal for ImmunoTherapy of Cancer, 10(11):e005288. BioMed Central Ltd.
BackgroundThe complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod. On the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caa6784953e399ce85d2a805a4a355de
https://doi.org/10.1136/jitc-2022-005288
https://doi.org/10.1136/jitc-2022-005288
Autor:
Anna J M, van de Sande, Coen M, Schreuder, Romy, van Baars, Margot M, Koeneman, Cornelis G, Gerestein, Arnold-Jan, Kruse, Folkert J, van Kemenade, Sten P, Willemsen, Heleen J, van Beekhuizen
Publikováno v:
Obstetrics and gynecology. 139(3)
To evaluate the efficacy and long-term outcome of repeat large loop excision of the transformation zone in women with residual or recurrent cervical intraepithelial neoplasia.PALGA (the Dutch Pathology Registry), a database of deidentified cervical c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8071fd1440f1150accc07986a99abab6
https://pubmed.ncbi.nlm.nih.gov/35115479
https://pubmed.ncbi.nlm.nih.gov/35115479
Autor:
Margot M. Koeneman, Rafli van de Laar, Arnold-Jan Kruse, Heleen J. van Beekhuizen, Roy F.P.M. Kruitwagen, Anna J. M. van de Sande, Kees G. Gerestein
Publikováno v:
Journal of Lower Genital Tract Disease, 20(1), 75-79. LIPPINCOTT WILLIAMS & WILKINS
Journal of Lower Genital Tract Disease, 20(1), 75-79. Lippincott Williams & Wilkins
Journal of Lower Genital Tract Disease, 20(1), 75-79. Lippincott Williams & Wilkins
Objective The aim of the study was to assess awareness, attitudes, and current clinical experiences of gynecologists regarding imiquimod as a potential treatment modality for vaginal intraepithelial neoplasia (VAIN) and cervical intraepithelial neopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68344bbb5d69b4b168d0bcc6b07e5eb3
https://cris.maastrichtuniversity.nl/en/publications/86cec9d6-06a2-4adc-b63d-e03918de995b
https://cris.maastrichtuniversity.nl/en/publications/86cec9d6-06a2-4adc-b63d-e03918de995b
Autor:
Dieuwke Boskamp, Carmen D. Dirksen, Arnold J. Kruse, Brigitte A. B. Essers, Cornelis G. Gerestein, Anna J. M. van de Sande, Rogier J.N.T.M. Litjens, Heleen J. Beekhuizen, Roy F.P.M. Kruitwagen, Margot M. Koeneman, Medi F.J. Goossens
Publikováno v:
Journal of Immunotherapy, 40(4), 148-153. LIPPINCOTT WILLIAMS & WILKINS
Journal of Immunotherapy, 40(4), 148-153. Lippincott Williams & Wilkins
Journal of Immunotherapy, 40(4), 148-153. Lippincott Williams & Wilkins
Imiquimod has been studied as a noninvasive pharmacological treatment alternative to large loop excision of the transformation zone (LLETZ) for high-grade cervical intraepithelial neoplasia (CIN), to prevent long-term obstetric complications from sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c3b7f6702dde810e3f0c09b3236f05
https://pubmed.ncbi.nlm.nih.gov/28221188
https://pubmed.ncbi.nlm.nih.gov/28221188